Axon Therapies Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$8M
- Investors
-
3
Axon Therapies General Information
Description
Developer of a healthcare device designed to reduce sympathetic nerve activity and address the root cause of heart failure. The company's device allows clinicians to ablate the right greater splanchnic nerve using a small catheter inserted through the groin and helps to normalize sympathetic nervous activity, to shift blood volume from the heart back to the splanchnic bed, reducing pressures in the heart, enabling clinicians to begin treatment quickly, resulting in a higher likelihood of successful treatment.
Contact Information
Website
www.axontherapies.comCorporate Office
- 2326 Walsh Avenue
- Santa Clara, CA 95051
- United States
Corporate Office
- 2326 Walsh Avenue
- Santa Clara, CA 95051
- United States
Axon Therapies Timeline
Axon Therapies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Debt - General | 25-Apr-2023 | $8M | Completed | Clinical Trials - General | ||
| 5. Later Stage VC (Series A) | 28-Jan-2021 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series A) | 07-Feb-2019 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC (Series AA) | 26-Jun-2017 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series AA) | 19-Apr-2016 | $2M | $2M | Completed | Clinical Trials - General | |
| 1. Accelerator/Incubator | Completed | Startup |
Axon Therapies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A V | ||||||||
| Series AA NV | ||||||||
| Series AA V | 1,650,000 | $0.001000 | $0.12 | $2 | $2 | 1x | $2 | 6.09% |
| Series A NV | 21,986,785 | $0.001000 | $0.12 | $1.48 | $1.48 | 1x | $1.24 | 0% |
Axon Therapies Comparisons
Industry
Financing
Details
Axon Therapies Competitors (15)
One of Axon Therapies’s 15 competitors is BioVentrix, a Venture Capital-Backed company based in San Ramon, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioVentrix | Venture Capital-Backed | San Ramon, CA | ||||
| Magnolia Medical Technologies | Venture Capital-Backed | Seattle, WA | ||||
| ClearFlow | Venture Capital-Backed | Irvine, CA | ||||
| Direct Flow Medical | Venture Capital-Backed | Santa Rosa, CA | ||||
| Bardy Diagnostics | Formerly VC-backed | Bellevue, WA |
Axon Therapies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Axon Therapies Patents
Axon Therapies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3220951-A1 | Methods, devices and systems for treating a patient by gsn ablation | Pending | 07-Jun-2021 | ||
| AU-2022290510-A1 | Methods, devices and systems for treating a patient by gsn ablation | Pending | 07-Jun-2021 | ||
| JP-2024520745-A | Method, device and system for treating a patient with gsn ablation | Pending | 07-Jun-2021 | ||
| EP-4351696-A1 | Methods, devices and systems for treating a patient by gsn ablation | Pending | 07-Jun-2021 | ||
| US-20240293176-A1 | Methods, devices and systems for treating a patient by gsn ablation | Pending | 07-Jun-2021 | A61B18/1492 |
Axon Therapies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Axon Therapies Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Deerfield Management | Venture Capital | Minority | ||
| Action Potential Venture Capital | Corporate Venture Capital | Minority | ||
| Coridea | VC-Backed Company |
Axon Therapies FAQs
-
When was Axon Therapies founded?
Axon Therapies was founded in 2014.
-
Where is Axon Therapies headquartered?
Axon Therapies is headquartered in Santa Clara, CA.
-
What is the size of Axon Therapies?
Axon Therapies has 17 total employees.
-
What industry is Axon Therapies in?
Axon Therapies’s primary industry is Surgical Devices.
-
Is Axon Therapies a private or public company?
Axon Therapies is a Private company.
-
What is Axon Therapies’s current revenue?
The current revenue for Axon Therapies is .
-
How much funding has Axon Therapies raised over time?
Axon Therapies has raised $43.8M.
-
Who are Axon Therapies’s investors?
Deerfield Management, Action Potential Venture Capital, and Coridea have invested in Axon Therapies.
-
Who are Axon Therapies’s competitors?
BioVentrix, Magnolia Medical Technologies, ClearFlow, Direct Flow Medical, and Bardy Diagnostics are some of the 15 competitors of Axon Therapies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
